TWITTER

• White Paper on Blindness to launch in EP
  

  Brussels, October 4th, 2017: A White Paper on blindness, entitled ‘Eyes Right: Preventable Blindness’ is set to be launched in the European Parliament in Brussels on Wednesday, 11 October.

  The launch will be augmented by a workshop one-day ahead of this year’s World Sight Day on 12 October, held under the banner ‘Make Vision Count’. This is an annual day of awareness to focus global attention on blindness, visual impairment and rehabilitation of the visually impaired, and was first held in 1998.  Please see the agenda.

• Press Release: European Prostate Cancer Awareness Day holds European Parliament event
  

  Brussels, 28 September, 2017: The Brussels-based European Alliance for Personalised Medicine (EAPM) was on hand in the European Parliament yesterday (27 September) to play its part in the annual European Prostate Cancer Awareness Day.

  The Alliance’s executive director, Denis Horgan, gave an account of the role personalised medicine can play in managing this disease, which is the most frequent cancer in men.

• Innovation in personalised medicine and healthcare as a whole is here among us and is moving swiftly.
  
  But policy, rules and regulations must keep up if we are to make the most of the many breakthroughs, optimise the use of Big Data and bring novel medicines to market more quickly.

  The Brussels-based European Alliance for Personalised Medicine (EAPM) has worked continuously to bring stakeholders together to find a way through the legislative labyrinth that surrounds many issues affecting personalised medicine.

• Charlie and the Medicine Factory
  

  In the famous final speech from the 1940 movie ‘The Great Dictator’, Charlie Chaplin’s character says: “I’m sorry, but I don’t want to be an emperor. That’s not my business. I don’t want to rule or conquer anyone. I should like to help everyone if possible… We all want to help one another. Human beings are like that.”

  He continues: “We want to live by each other’s happiness, not by each other’s misery…The way of life can be free and beautiful, but we have lost the way…We think too much and feel too little.”

• Managing expectations: Hype v. Hope
  

  With modern-day medicine going the way it is - new developments, great science, the advent of personalised medicine and more - there’s little doubt that healthcare can move in the right direction if everything is put in place to allow it to do so.

  There are, of course, plenty of barriers to integrating personalised medicine into the EU’s healthcare systems, but perhaps one of the most surprising is a lack of willingness to buy-in to the incredible advances by those who have most to gain down the line.

• Better Regulation in the EU - Are the law aligning?
  

  We are halfway through this European Parliament’s mandate and, as ever, many laws have been voted on centrally with many more to come, but will they actually be effectively introduced at national level in the area of health?

  And in the often-bewildering era of ‘post-truth’, it is most definitely time to listen to healthcare experts and stakeholders when it comes to formulating strategies and delivering on promises.

• Unhealthy divisions don’t help access to best healthcare
  

  As we stand, today, post-Brexit vote and with Donald J. Trump newly ensconced in The White House, the divisions in key parts of the Western world are clear and stark.

  Across the United States, women (and men) marched in protest after the inauguration of the 45th president, in scenes unheard of for such an event. 

• This is the modern world: Time for regulation to move with the times
  

  Almost one year ago, the European Commission (and its independent Expert Panel on effective ways of investing in health) launched a public consultation on a preliminary opinion, which explored “the implications of disruptive innovation for health and healthcare in Europe”. writes Denis Horgan, Executive Director, European Alliance for Personalised Medicine. 

  It described disruptive innovation as “a type of innovation that creates new networks and players that tend to displace existing structures and actors. It constitutes a real paradigm shift in the organisation of healthcare”.

[ 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | next ] pages: 14